Free Trial
→ Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th... (From Banyan Hill Publishing) (Ad)tc pixel Free GDTC Stock Alerts

CytoMed Therapeutics (GDTC) Short Interest Ratio & Short Volume

CytoMed Therapeutics logo
$1.13 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$1.15 +0.02 (+1.77%)
As of 05/22/2026 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CytoMed Therapeutics Short Interest Overview

As of April 30, 2026, CytoMed Therapeutics (GDTC) had a short interest of 68,135 shares sold short, representing 0.58% of the public float. This marks a -5.30% decrease in short interest since the prior report. The short interest ratio (days to cover) is 11.2, meaning it would take 11.2 days of the average trading volume of 28,576 shares to cover all short positions.

Current Short Interest
68,135 shares
Previous Short Interest
71,945 shares
Change Vs. Previous Month
-5.30%
Dollar Volume Sold Short
$67.93 thousand
Short Interest Ratio
11.2 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
11,830,000 shares
Short Percent of Float
0.58%
Today's Trading Volume
16,025 shares
Average Trading Volume
28,576 shares
Today's Volume Vs. Average
56%
Short Selling CytoMed Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for CytoMed Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GDTC Short Interest Over Time

GDTC Days to Cover Over Time

GDTC Percentage of Float Shorted Over Time

CytoMed Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202668,135 shares $67.93 thousand -5.3%0.6%11.22 $1.00
11/14/202522,080 shares $43.28 thousand +31.3%N/A0.13 $1.96
10/31/202516,818 shares $37.00 thousand -83.8%N/A0.09 $2.20
10/15/2025103,700 shares $233.33 thousand +263.9%2.3%1.5 $2.25
9/30/202528,500 shares $56.72 thousand -33.6%0.6%1.7 $1.99
9/15/202542,900 shares $91.16 thousand +28.1%1.0%3.3 $2.13
8/31/202533,500 shares $68.01 thousand -11.8%0.8%3 $2.03
8/15/202538,000 shares $68.40 thousand -2.3%0.9%3.1 $1.80
7/31/202538,900 shares $73.72 thousand -27.3%0.8%3.6 $1.90
7/15/202553,500 shares $109.14 thousand -20.6%1.1%4.6 $2.04
6/30/202567,400 shares $151.65 thousand +18.7%1.4%4.6 $2.25
6/15/202556,800 shares $120.53 thousand -12.9%1.2%3.5 $2.12
5/31/202565,200 shares $151.26 thousand -11.1%1.2%3.7 $2.32
5/15/202573,300 shares $171.52 thousand -4.8%1.4%4.1 $2.34
4/30/202577,000 shares $182.49 thousand -12.2%1.5%4.2 $2.37
4/15/202587,700 shares $205.22 thousand -6.8%1.8%4.4 $2.34
3/31/202594,100 shares $207.02 thousand -6.8%2.0%0.5 $2.20
3/15/2025101,000 shares $250.48 thousand -21.0%2.1%0.5 $2.48
2/28/2025127,800 shares $350.17 thousand -13.5%3.2%0.6 $2.74
2/15/2025147,800 shares $378.37 thousand -22.5%3.1%0.7 $2.56
1/31/2025190,600 shares $503.18 thousand -15.6%4.0%1 $2.64
1/15/2025225,900 shares $494.72 thousand +174.8%4.7%1.1 $2.19
12/31/202482,200 shares $279.48 thousand +31.1%1.7%0.4 $3.40
12/15/202462,700 shares $170.26 thousand -17.1%1.3%3.2 $2.72
11/30/202475,600 shares $177.66 thousand -1.6%1.6%4.4 $2.35
11/15/202476,800 shares $166.99 thousand -19.4%1.6%6.3 $2.17
10/31/202495,300 shares $229.67 thousand -17.9%2.0%7.7 $2.41
10/15/2024116,100 shares $241.49 thousand -2.4%2.5%10 $2.08
9/30/2024118,900 shares $186.67 thousand -3.1%2.5%1.7 $1.57
9/15/2024122,700 shares $184.05 thousand -2.3%2.6%1.9 $1.50
8/31/2024125,600 shares $186.05 thousand +5.3%2.7%1.9 $1.48
8/15/2024119,300 shares $206.39 thousand -9.4%2.5%1.8 $1.73
7/31/2024131,600 shares $238.20 thousand +240.9%2.8%2 $1.81
7/15/202438,600 shares $77.20 thousand -1.8%0.8%0.6 $2.00
6/30/202439,300 shares $81.74 thousand +1.3%0.8%10.1 $2.08
6/15/202438,800 shares $73.72 thousand +9.9%0.8%8.6 $1.90
5/31/202435,300 shares $76.25 thousand -8.3%0.8%5.8 $2.16
5/15/202438,500 shares $85.86 thousand -10.3%1.0%5.4 $2.23
4/30/202442,900 shares $90.52 thousand +8.9%1.1%3 $2.11
4/15/202439,400 shares $79.59 thousand +11.6%1.0%1.6 $2.02
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
3/31/202435,300 shares $76.60 thousand +82.9%0.9%1.2 $2.17
3/15/202419,300 shares $41.11 thousand No Change0.5%0.4 $2.13
2/29/202419,300 shares $38.79 thousand -15.7%0.5%0.4 $2.01
2/15/202422,900 shares $57.48 thousand +593.9%0.6%0.4 $2.51
1/31/20243,300 shares $11.68 thousand -58.2%0.1%0.1 $3.54
1/15/20247,900 shares $32.63 thousand -54.3%0.2%0.2 $4.13
12/31/202317,300 shares $84.77 thousand +1,135.7%0.4%0.5 $4.90
12/15/20231,400 shares $4.75 thousand -63.2%0.0%0.1 $3.39
11/30/20233,800 shares $14.02 thousand +245.5%0.1%0.6 $3.69
11/15/20231,100 shares $4.41 thousand -54.2%0.0%0.2 $4.01
10/31/20232,400 shares $8.95 thousand -50.0%0.1%0.2 $3.73
10/15/20234,800 shares $16.94 thousand -20.0%0.1%0.3 $3.53
9/30/20236,000 shares $21 thousand -25.9%0.2%0 $3.50
9/15/20238,100 shares $30.46 thousand -5.8%0.2%0 $3.76
8/31/20238,600 shares $28.98 thousand +30.3%0.2%0 $3.37
8/15/20236,600 shares $24.88 thousand -50.0%0.2%0 $3.77
7/31/202313,200 shares $57.16 thousand -92.2%0.3%0 $4.33
7/15/2023169,600 shares $736.06 thousand +198.6%4.3%0.3 $4.34
6/30/202356,800 shares $173.24 thousand +24.6%1.5%0.1 $3.05
6/15/202345,600 shares $129.50 thousand -27.2%1.2%0.3 $2.84
5/31/202362,600 shares $170.90 thousand +67.8%1.8%0.3 $2.73
5/15/202337,300 shares $114.88 thousand No Change1.1%0.1 $3.08

GDTC Short Interest - Frequently Asked Questions

Short interest is the volume of CytoMed Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 68,135 shares of GDTC short. 0.58% of CytoMed Therapeutics' shares are currently sold short. Learn More on CytoMed Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GDTC shares currently have a short interest ratio of 11.2. Learn More on CytoMed Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of CytoMed Therapeutics' floating shares are currently sold short.

CytoMed Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 68,135 shares, a drop of 5.3% from the previous total of 71,945 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.58% of CytoMed Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CytoMed Therapeutics: INmune Bio, Inc. (16.86%), Elutia Inc. (0.41%), Atossa Genetics Inc. (4.35%), Telomir Pharmaceuticals, Inc. (2.98%), Lite Strategy, Inc. (0.27%), Hyperion DeFi, Inc. (9.21%), Synaptogenix, Inc. (8.63%), Aligos Therapeutics, Inc. (8.58%), Athira Pharma, Inc. (5.07%), MIRA Pharmaceuticals, Inc. (1.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling GDTC is an investing strategy that aims to generate trading profit from CytoMed Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CytoMed Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GDTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GDTC, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GDTC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:GDTC) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Skip the Line Opportunity: The SpaceX IPO
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
FINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHT
Tim Plaehn's income ETF research is available at 82% off - but only until midnight tonight. This Memorial Day ...
Investors Alley | Sponsoredtc pixel